Download PDF
Rofo 2002; 174(7): 819-829
DOI: 10.1055/s-2002-32689
Übersicht
© Georg Thieme Verlag Stuttgart · New York

Anwendung von Kontrastmitteln für die kardiale Magnetresonanztomographie

MR contrast media for cardiovascular imagingG.  A.  Krombach1 2 , C.  B.  Higgins1 , R.  W.  Günther2 , T.  Kühne1 , M.  Saeed1
  • 1Department of Radiology, University of California, San Francisco, California, USA
  • 2Klinik für Radiologische Diagnostik, Universitätsklinikum der RWTH Aachen, Aachen, Deutschland
Further Information

Publication History

Publication Date:
08 July 2002 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

MR Kontrastmittel können die diagnostische Aussagekraft der MRT verbessern und werden erfolgreich zur Differenzierung von vitalem und nekrotischem Myokard, transmuralem und nicht-transmuralem Infarkt, reperfundiertem und nicht-reperfundiertem Infarkt sowie für myokardiale Perfusionsmessungen eingesetzt. Derzeit sind klinische Studien nahezu ausschließlich auf die Anwendung extrazellulärer Kontrastmittel beschränkt (z. B. Gd-DTPA, Gd-DTPA-BMA, Gd-BOPTA, Gd-D03A). Die Differenzierung und Charakterisierung ischämisch geschädigten Myokards mittels exogener Substanzen wie intravaskulärer, nekroseaffiner und intrazellulärer Kontrastmittel oder die Nutzung endogener Substrate als Kontrastgeber konnte jedoch in experimentellen Untersuchungen gezeigt werden. Intravaskuläre Kontrastmittel (z. B. MS-325 oder Eisenpartikel) erlauben die Untersuchung der Integrität des Kapillarsystems sowie die MR-Angiographie. Nekroseaffine Kontrastmittel (z. B. Gadophrin) wurden zur selektiven Darstellung infarzierten Gewebes eingesetzt. Intrazelluläre Kontrastmittel (z. B. Mn-DPDP) ermöglichen die Darstellung vitalen Myokards. Endogene Substanzen (z. B. Deoxyhämoglobin, Na+ oder K+) wurden zur Darstellung der veränderten Ionenhomöostase und für Perfusionsmessungen in ischämisch geschädigtem Myokard erprobt.

Abstract

MR contrast media improve the diagnostic capability of MRI and MRA. They are used in the discrimination of viable and non-viable myocardium, transmural and non-transmural infarction, occlusive and reperfused infarction and for measurement of myocardial perfusion. Currently, clinical studies are almost completely restricted to the use of extracellular non-specific MR contrast media (i. e., Gd-DTPA, Gd-DTPA,-BMA, Gd-BOPTA, Gd-D03A). However, the feasibility of using intravascular, necrosis specific or intracellular MR contrast media or endogeneous substrates as specific MR contrast media in cardiovascular imaging has been demonstrated in experimental and a few clinical studies. Intravascular contrast media (i. e., MS-325 or NC100150 Injection) allow assessment of microvascular integrity and performance of MR angiography. Necrosis specific contrast media (i. e., Gadophrin-2) have been used for sizing the extent of infarcted myocardium while intracellular contrast media (i. e., Mn-DPDP) delineate viable myocardium. Endogenous contrast media (i. e., Deoxyhemoglobin, Na+ or K+) have been tested for detecting the alterations in concentrations of these ions in infarcted myocardium and for perfusion measurements. Furthermore, intravascular MR contrast media may be useful for MRA and MRI guided cardiovascular interventions.

Schlüsselwörter

MRT Kontrastmittel - Kardiovaskuläre MRT - Myokardinfarkt - Myokardvitalität - Interventionelle kardiovaskuläre Magnetresonanztomographie

Key words

MRI contrast media - Cardiovascular MRI - Myocardial infarction - Myocardial viability - Interventional magnetic resonance imaging

Literatur

  • 1 Matheijssen N A, Louwerenburg H W, Van Rugge F P, Arens R P, Kauer B, de Roos A, van der Wall E E. Comparison of ultrafast dipyridamole magnetic resonance imaging with dipyridamole SestaMIBI SPECT for detection of perfusion abnormalities in patients with one-vessel coronary artery disease: assessment by quantitative model fitting.  Magn Reson Med. 1996;  35 221-228
    PubMedGoogle Scholar
  • 2 Saeed M, Wendland M F, Lauerma K, Sakuma H, Chew W, Derugin N, Higgins C B. First-pass contrast-enhanced inversion recovery and driven equilibrium fast GRE imaging studies: detection of acute myocardial ischemia.  J Magn Reson Imaging. 1995;  5 515-523
    PubMedGoogle Scholar
  • 3 Wendland M F, Saeed M, Masui T, Derugin N, Higgins C B. First pass of a MR susceptibility contrast agent through normal and ischemic heart: gradient-recalled echo-planar imaging.  J Magn Reson Imaging. 1993;  3 755-760
    PubMedGoogle Scholar
  • 4 Van der Wall E E, van Dijkman P R, de Roos A, Doornbos J, van der Laarse A, Manger Cats V, van Voorthuisen A E, Matheijssen N A, Bruschke A V. Diagnostic significance of Gd-DTPA (diethylenetriamine penta-acetic acid) enhanced magnetic resonance imaging in thrombolytic treatment for acute myocardial infarction: its potential in assessing reperfusion.  Br Heart J. 1990;  63 12-17
    PubMedGoogle Scholar
  • 5 Saeed M, Watzinger N, Krombach G A, Lund G K, Wendland M F, Chujo M, Higgins C B. Sequential MRI of post-infarcted left ventricular remodeling: value of nicorandil therapy in rat model.  Radiology. 2002;  im Druck
    PubMedGoogle Scholar
  • 6 Wagenseil J, Johansson L OM, Lorenz C H. Characterization of T1-Relaxation and blood-myocardial contrast enhancement of NC100150 Injection in cardiac MRI.  J Magn Reson Imaging. 1999;  10 784-789
    CrossrefPubMedGoogle Scholar
  • 7 Gallez B, Bacic G, Swartz H M. Evidence for the dissociation of the hepatobiliary MRI contrast agent Mn-DPDP.  Magn Reson med. 1996;  35 14-19
    PubMedGoogle Scholar
  • 8 Bemerich J, Saeed M, Arheden H, Higgins C B, Wendland M F. Normal and infarcted myocardium: differentiation with cellular uptake of manganese at MR imaging in a rat model.  Radiology. 2000;  216 524-530
    PubMedGoogle Scholar
  • 9 Arheden H, Saeed M, Higgins C B, Gao D W, Bremerich J, Wyttenbach R, Dae M W, Wendland M F. Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify moycardial infarction: comparison with 99mTc-DTPA autoradiography in rats.  Radiology. 1999;  211 698-708
    PubMedGoogle Scholar
  • 10 Dendale P, Franken P R, Meusel M, van der Geest R, de Roos A. Distinction between open and occluded infarct-related arteries using contrast-enhanced magnetic resonance imaging.  Am J Cardiol. 1997;  80 334-336
    CrossrefPubMedGoogle Scholar
  • 11 Aukland K, Reed R K. Interstitial-lymphatic mechanisms in the control of extracellular fluid volume.  Physiol Rev. 1993;  71 1-78
    PubMedGoogle Scholar
  • 12 Saeed M, Higgins C B, Geschwind J F, Wendland M F. T1-relaxation kinetics of extracellular, intracellular, and intravascular MR contrast agentsin normal and acutely reperfused infarcted myocardium using echoplanar MR imaging.  Eur Radiol. 2000;  10 310-318
    CrossrefPubMedGoogle Scholar
  • 13 Diesbourg L D, Prato F S, Wisenberg G, Drost D J, Marshall T P, Carroll S E, O'Neill B. Quantification of myocardial blood flow and extracellular volumes using a bolus injection of Gd-DTPA: kinetic modeling in canine ischemic disease.  Magn Reson Med. 1992;  23 239-253
    PubMedGoogle Scholar
  • 14 Tong C Y, Prato F S, Wiesenberg G, Lee T Y, Carroll E, Sander D, Wills J, Drost D. Measurements of the extraction efficiency and distribution volume for Gd-DTPA in normal and diseased canine myocardium.  Magn Reson Med. 1993;  30 337-346
    PubMedGoogle Scholar
  • 15 Flacke S, Fischer S E, Lorenz C H. Measurement of the gadopentate dimeglumine partition coefficient in human myocardium in vivo: normal distribution and evaluation in acute and chronic infarction.  Radiology. 2001;  218 703-710
    PubMedGoogle Scholar
  • 16 Arheden H, Saeed M, Higgins C B, Gao D W, Ursell P C, Bremerich J, Wyttenbach R, Dae M W, Wendland M F. Reperfused rat myocardium subjected to various durations of ischemia: Estimation of the distribution volume of contrast material with echoplanar MR imaging.  Radiology. 2000;  275 520-528
    PubMedGoogle Scholar
  • 17 Saeed M, Lund G, Wendland M F, Bremerich J, Weinmann H J, Higgins C B. Magnetic resonance characterization of the peri-infarction zone of reperfused myocardial infarction with necrosis-specific and extracellular nonspecific contrast media.  Circulation. 2001;  103 871-876
    PubMedGoogle Scholar
  • 18 Pislaru S V, Ni Y, Pislaru C, Bosmans H, Miao Y, Bogaert J, Dymarkowski S, Semmler W, Marchal G, Van de Werf F J. Noninvasive measurements of infarct size after thrombolysis with a necrosis-avid MRI contrast agent.  Circulation. 1999;  99 690-696
    PubMedGoogle Scholar
  • 19 Rogers W J, Kramer C M, Geskin G, Hu Y L, Theobald T M, Vido D A, Petruolo S, Reichek N. Early contrast-enhanced MRI predicts late functional recovery after reperfused myocardial infarction.  Circulation. 1999;  99 744-750
    PubMedGoogle Scholar
  • 20 Sandstede J JW, Pabst T, Beer M, Lipke C, Bäurle K, Butter F, Harre K, Kenn W, Voelker W, Neubauer S, Hahn D. Assessment of myocardial infarction in humans with 23Na MR imaging: comparison with CINE MR imaging and delayed contrast enhancement.  Radiology. 2001;  221 222-228
    PubMedGoogle Scholar
  • 21 Oshinski J N, Yang Z, Jones J R, Mata J F, French B A. Imaging time after Gd-DTPA Injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging.  Circulation. 2001;  104 2838-2842
    CrossrefPubMedGoogle Scholar
  • 22 Kim R J, Fieno D S, Parrish T B, Harris K, Chen E L, Simonetti O, Bundy J, Finn P, Klocke F J, Judd R M. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.  Circulation. 1999;  100 1992-2002
    CrossrefPubMedGoogle Scholar
  • 23 Choi K M, Kim R J, Gubernikoff G, Vargas B S, Parker M, Judd R M. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function.  Circulation. 2001;  104 1101-1107
    PubMedGoogle Scholar
  • 24 Saeed M, Wendland M F, Masui T, Higgins C B. Reperfused myocardial infarctions on T1- and susceptibility-enhanced MRI: evidence for loss of compartimentalization of contrast media.  Magn Reson Med. 1994;  31 31-39
    PubMedGoogle Scholar
  • 25 Thornhill R E, Prato F S, Pereira R S, Wisenberg G, Sykes J. Examining a canine model of stunned myocardium with Gd-DTPA-enhanced MRI.  Magn Reson Med. 2001;  45 864-871
    CrossrefPubMedGoogle Scholar
  • 26 Manning W J, Atkinson D J, Grossman W, Paulin S, Edelman R R. First-pass nuclear magnetic resonance imaging studies using Gadolinium-DTPA in patients with coronary artery disease.  J Am Coll Cardiol. 1991;  18 959-965
    PubMedGoogle Scholar
  • 27 Ochiai K, Shimada T, Murakami Y. Hemorrhagic myocardial infarction after coronary reperfusion detected in vivo by magnetic resonance imaging in humans: prevalence and clinical implications.  J Cardiovasc Magn Reson. 1999;  1 247-256
    PubMedGoogle Scholar
  • 28 Wilke N, Jerosch-Herold M, Zenovich A, Stillman A E. Magnetic resonance first-pass myocardial perfusion imaging: clinical validation and future applications.  J Magn Reson Imaging. 1999;  10 676-685
    CrossrefPubMedGoogle Scholar
  • 29 Saeed M, Wendland M F, Yu K K, Lauerma K, Li H T, Derugin N, Cavagna F M, Higgins C B. Identification of myocardial reperfusion with echo-planar magnetic resonance imaging: discrimination between occlusive and reperfused infarctions.  Circulation. 1994;  90 1492-1501
    PubMedGoogle Scholar
  • 30 Judd R M, Lugo-Olivieri C H, Arai M, Kondo T, Croisille P, Lima J A, Mohan V, Becker L C, Zerhouni E A. Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-days-old reperfused canine infarcts.  Circulation. 1995;  92 1902-1910
    CrossrefPubMedGoogle Scholar
  • 31 Rochitte C E, Lima J A, Blumcke D A, Reeder S B, McVeigh E R, Furuta T, Becker L C, Melin J A. Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction.  Circulation. 1998;  98 1006-1014
    PubMedGoogle Scholar
  • 32 Weissleder R, Lee A S, Khaw B A, Shen T, Brady T J. Antimyosin-labeled monocrystalline iron oxide allows detection of myocardial infarction: MR antibody imaging.  Radiology. 1992;  182 381-385
    PubMedGoogle Scholar
  • 33 Marchal G, Ni Y, Herijgers P, Flameng W, Petré C, Bosmans H, Yu J, Ebert W, Pfefferer D, Semmler W, Baert A L. Paramagnetic metalloporphyrins: infarct avid contrast agents for diagnosis of acute myocardial infarction by MRI.  Eur Radiol. 1996;  6 2-8
    CrossrefPubMedGoogle Scholar
  • 34 Saeed M, Bremerich J, Wendland M F, Wyttenbach R, Weinmann H J, Higgins C B. Reperfused myocardial infarction as seen with use of necrosis-specific versus standard extracellular MR contrast media in rats.  Radiology. 1999;  213 247-257
    PubMedGoogle Scholar
  • 35 Lund G, Higgins C B, Wendland M F, Watzinger N, Weinmann H J, Saeed M. Assessment of nicorandil therapy in ischemic myocardial injury.  Radiology. 2001;  221 676-682
    PubMedGoogle Scholar
  • 36 Brurok H, Schjott J, Berg K, Karlsson J O, Jynge P. Effects of Mn-DPDP, DPDP- and MnCl2 on cardiac energy metabolism and manganese accumulation. An experimental study in the isolated perfused rat heart.  Invest Radiol. 1997;  32 205-211
    CrossrefPubMedGoogle Scholar
  • 37 Krombach G A, Saeed M, Novikov V, Higgins C B, Wendland M F. Delineation of cellular uptake of manganese with MRI for differentiation of stunned and normal myocardium.  Radiology. 2001;  221 (P) 586
    PubMedGoogle Scholar
  • 38 Rochitte C E, Kim R J, Hillenbrand H B, Chen E L, Lima J A. Microvascular integrity and the time course of myocardial sodium accumulation after acute infarction.  Circ Res. 2000;  87 648-655
    PubMedGoogle Scholar
  • 39 Kim R J, Lima J A, Chen E L, Reeder S B, Klocke F J, Zerhouni E A, Judd R M. Fast 23Na magnetic resonance imaging of acute reperfused myocardial infarction.  Circulation. 1997;  95 1877-1885
    PubMedGoogle Scholar
  • 40 Fieno D S, Kim R J, Rehwald W G, Judd R M. Physiological basis for potassium (39K) magnetic resonance imaging of the heart.  Circ Res. 1999;  84 913-920
    PubMedGoogle Scholar
  • 41 Li D, Dhawale P, Rubin P J, Haacke E M, Gropler R J. Myocardial signal response to dipyridamole and dobutamine: demonstration of the BOLD effect using a double-echo gradient-echo sequence.  Magn Reson Med. 1996;  36 16-20
    CrossrefPubMedGoogle Scholar
  • 42 Wacker C M, Bock M, Hartlep A W, Bauer W R, van Kaick G, Pfleger S, Ertl G, Schad L R. BOLD-MRI in ten patients with coronary artery disease: evidence for imaging of capillary recruitment in myocardium supplied by the stenotic artery.  Magma. 1999;  8 48-54
    PubMedGoogle Scholar
  • 43 Bache G M, Herzka D A, Boxerman J L, Post W S, Gupta S N, Faranesh A Z, Solaiyappan M, Bottomley P A, Weiss J L, Shapiro E P, Hill M N. Attenuated myocardial vasodilatator response in patients with hypertensive hypertrophy revealed by oxygenation-dependent magnetic resonance imaging.  Circulation. 2001;  104 1214-1217
    PubMedGoogle Scholar
  • 44 Waller C, Hiller K H, Voll S, Haase A, Ertl G, Bauer W R. Myocardial perfusion imaging using a non-contrast MR imaging technique.  Int J Card Imaging. 2001;  17 123-132
    CrossrefPubMedGoogle Scholar
  • 45 Williams D S, Detre J A, Leigh J S, Koretsky A P. Magnetic resonance imaging of perfusion using spin inversion of arterial water.  Proc Natl Acad Sci USA. 1992;  89 212-216
    CrossrefPubMedGoogle Scholar
  • 46 Asanuma T, Tanabe K, Ochiai K, Yoshitomi H, Nakamura K, Murakami Y, Sano K, Shimada T, Murakami R, Morioka S, Beppu S. Relationship between progressive microvascular damage and intramyocardial hemorrhage in patients with reperfused anterior myocardial infarction: myocardial contrast echocardiographic study.  Circulation. 1997;  96 448-458
    PubMedGoogle Scholar
  • 47 Gerber B L, Rochitte C E, Melin J A, McVeigh E R, Bluemke D A, Wu K C, Lima J A. Microvascular obstruction and left ventricular remodeling early after acute myocardial infarction.  Circulation. 2000;  101 2734-2741
    PubMedGoogle Scholar
  • 48 Bremerich J, Wendland M F, Arheden H, Wyttenbach R, Gao D W, Huberty J P, Dae M W, Higgins C B, Saeed M. Microvascular injury in reperfused infarcted myocardium: noninvasive assessment with contrast-enhanced echoplanar magnetic resonance imaging.  J Am Coll Cardiol. 1998;  32 787-793
    CrossrefPubMedGoogle Scholar
  • 49 Wu K C, Kim R J, Blumke D A, Rochitte C E, Zerhouni E A, Becker L C, Lima J A. Quantification and time course of microvascular obstruction by contrast-enhanced echocardiography and magnetic resonance imaging following acute myocardial infarction and reperfusion.  J Am Coll Cardiol. 1998;  32 1756-1764
    CrossrefPubMedGoogle Scholar
  • 50 Bücker A, Adam G, Neuerburg J, Glowinski A, Tacke J, Günther R W. Interventionelle Magnetresonanztomographie.  Fortschr Röntgenstr. 2000;  173 105-111
    PubMedGoogle Scholar
  • 51 Bücker A, Adam G, Neuerburg J, Schürmann K, Rasche V, Molgaard-Nielsen A, Günther R W. Echtzeit-MR mit radialer k-Raumabtastung zur Überwachung angiographischer Interventionen.  Fortschr Röntgenstr. 1998;  169 542-546
    PubMedGoogle Scholar
  • 52 Bücker A, Neuerburg J M, Adam G B, Glowinski A, Schaefftler T, Rasche V, van Valls J J, Günther R W. Real-time MR guidance for inferior vena cava filter placement in an animal model.  J Vascul Intervent Radiol. 2001;  12 753-756
    PubMedGoogle Scholar
  • 53 Bücker A, Neuerburg J M, Adam G B, Glowinski A, Schaefftler T, Rasche V, van Vaals J J, Molgaard-Nielsen A, Günther R W. Real-time MR fluoroscopy for MR-guided iliac artery stent placement.  J Magn Reson Imaging. 2000;  12 616-622
    CrossrefPubMedGoogle Scholar
  • 54 Manke C, Nitz W R, Djavidani B, Strotzer M, Lenhart M, Välk M, Feuerbach S, Link J. MR imaging-guided stent placement in iliac arterial stenoses: a feasibility study.  Radiology. 2001;  219 527-534
    CrossrefPubMedGoogle Scholar
  • 55 Serfaty J M, Yang X, Aksit P, Quick H H, Solaiyappan M, Atalar E. Toward MRI-guided coronary catheterization: visualization of guiding catheters, guidewires, and anatomy in real time.  J Magn Reson Imaging. 2000;  12 590-594
    CrossrefPubMedGoogle Scholar
  • 56 Spuentrup E, Ruebben A, Schaeffter T, Manning W J, Günther R W, Buecker A. Magnetic resonance-guided coronary artery stent placement in a swine model.  Circulation. 2002;  105 874-879
    CrossrefPubMedGoogle Scholar
  • 57 Bakker C JG, Bos C, Weinmann H J. Passive tracking of catheters and guidewires by contrast-enhanced MR fluoroscopy.  Magn Reson Med. 2001;  45 18-23
    PubMedGoogle Scholar
  • 58 Mardor Y, Barbash I M, Feinberg M, Tessone A, Aboulafia-Etzion S, Orenstein A, Ruiz-Cabello J, Cohen J S, Leor J. Interventional MRI for monitoring changes in morphology of rat heart following myocardial infarction and assessing guided percutaneous therapy.  Proc Intl Soc Mag Reson Med. 2001;  9 1909
    PubMedGoogle Scholar

Maythem Saeed, DVM, PhD

Department of Radiology, University of California, San Francisco

505 Parnassus Avenue, L 308

San Francisco, CA 94143-0628

USA

Phone: + 1-415-476-0439

Fax: + 1-415-476-0616

Email: Maythem.Saeed@radiology.ucsf.edu

      >